Back to articles
Comparative guide · 6 min read

Berberine vs Cinnamon — which one actually moves blood sugar?

Updated 2026-05-10 · Reviewed by SupplementScore editors · No sponsorships

Both are sold at every supplement aisle for "blood sugar support." The trial evidence is in different leagues. Berberine has produced HbA1c reductions in type 2 diabetes that approach metformin in head-to-head trials — large effects, real metabolic action, real drug interactions. Cinnamon's effects are smaller, depend strongly on which preparation you use, and are inconsistent across meta-analyses. The marketing usually conflates them; the data does not.

Quick verdict

GoalBetter choiceWhy
HbA1c reduction in type 2 diabetes (adjunct) Berberine Yin 2008 and multiple meta-analyses show ~0.7% HbA1c reduction vs placebo, comparable to metformin in some head-to-head trials.
Mild fasting glucose nudge in metabolically healthy users Cinnamon Modest fasting glucose effect (~5–10 mg/dL) in some meta-analyses; safety is much higher than berberine for general use.
Lipid panel improvement Berberine Consistent reductions in LDL-C and triglycerides in addition to glucose effects.
PCOS / insulin resistance adjunct Berberine Trials in PCOS show comparable insulin sensitivity improvements to metformin with often better tolerability.
"I just want to support normal glucose" (no diagnosis) Probably Cinnamon — or neither Berberine's drug-interaction profile is too aggressive for casual use. Diet and movement do more than either supplement.
Best safety profile in non-diabetics Cinnamon (Ceylon) Ceylon cinnamon is low in coumarin and broadly safe. Cassia cinnamon contains hepatotoxic coumarin at higher levels.

How they compare on the things that matter

Mechanism — different pathways, different magnitudes

Berberine activates AMPK (adenosine monophosphate-activated protein kinase) — the same metabolic master switch that metformin acts on. Downstream this means improved hepatic insulin sensitivity, reduced hepatic glucose output, and modulation of gut microbial metabolism. The pharmacology is real, the effect size is real, and the drug-interaction footprint is real.

Cinnamon's bioactive components include cinnamaldehyde and proanthocyanidins, with proposed mechanisms involving improved insulin signalling and slowed gastric emptying. The effects are smaller and inconsistent — in part because "cinnamon" in trials varies wildly between Cassia and Ceylon species, between aqueous and lipid extracts, and across doses from 1 g to 6 g/day.

Evidence base by clinical endpoint

Practical rule. If you have measured insulin resistance or T2D and your clinician is on board, berberine is a credible adjunct that should be discussed alongside your medication list. If you're a healthy adult curious about "blood sugar support," start with diet, sleep, and resistance training — both supplements are downstream of those, and Ceylon cinnamon is the safer default if you do supplement.

Dose and form

For berberine, the trial-cited dose is 500 mg three times daily with meals. The bioavailability is poor (~5%); some preparations (dihydroberberine, sustained-release) claim improved absorption but the trial weight is on standard berberine HCl 500 mg t.i.d. Splitting the dose matters — 1500 mg once daily has more GI side effects and worse efficacy.

For cinnamon, doses across positive trials run 1–6 g/day, with 1–3 g/day most common. Use Ceylon (Cinnamomum verum), not Cassia (Cinnamomum aromaticum) for daily use. Cassia contains coumarin at levels where regular use exceeds the EFSA tolerable daily intake and has caused liver injury in case reports. Ceylon coumarin levels are roughly 1/250th of Cassia.

Safety

Berberine commonly causes GI upset (cramping, diarrhoea, constipation) — mostly dose-dependent and often improves over 2–3 weeks. The bigger issue is drug interactions — a complete medication list and clinician sign-off should be the starting point, not an afterthought. Berberine is not for use in pregnancy or lactation; it crosses the placenta and there's a kernicterus signal in newborns.

Cinnamon (Ceylon) is broadly safe. Cassia at supplement doses chronically can drive coumarin exposure into hepatotoxic territory in susceptible users. Cinnamon may potentiate hypoglycaemic medications modestly but is far less aggressive than berberine.

What the price difference buys you

Berberine runs roughly $0.40–0.80/day at the trial-cited 1500 mg/day dose. Ceylon cinnamon is essentially a kitchen spice and runs cents per day. Combination "blood sugar" stacks containing sub-therapeutic doses of both plus chromium/banaba/bitter melon are typically not a good deal — you're paying for marketing, not effect.

Who should skip each

Berberine should be avoided in pregnancy and lactation, in anyone on multiple chronic medications without explicit clinician sign-off (the CYP3A4 interaction list is long), and in anyone with a transplant or on tacrolimus/cyclosporine. People with established T2D managed by clinicians should not self-add it without coordinating insulin and oral hypoglycaemic doses — the additive effect can produce hypoglycaemia.

Cinnamon (Cassia) at supplement doses chronically should be avoided due to coumarin. Cinnamon (Ceylon) is generally safe; the main caution is the modest additive effect on hypoglycaemia in users on diabetes medications.

What we'd actually buy

For confirmed T2D or PCOS-related insulin resistance, in coordination with a clinician: berberine HCl 500 mg three times daily with meals, with baseline labs and a 12-week reassessment.

For general kitchen-and-cabinet glucose hygiene: Ceylon cinnamon 1–2 g/day in food, treating it as a flavour rather than a serious intervention. The evidence supports it being safe; it does not support it being transformative.

Sources

Read more: